1. Home
  2. HALO vs WCC Comparison

HALO vs WCC Comparison

Compare HALO & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • WCC
  • Stock Information
  • Founded
  • HALO 1998
  • WCC 1922
  • Country
  • HALO United States
  • WCC United States
  • Employees
  • HALO N/A
  • WCC N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • WCC Telecommunications Equipment
  • Sector
  • HALO Health Care
  • WCC Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • WCC Nasdaq
  • Market Cap
  • HALO 7.4B
  • WCC 8.0B
  • IPO Year
  • HALO N/A
  • WCC 1999
  • Fundamental
  • Price
  • HALO $65.87
  • WCC $161.86
  • Analyst Decision
  • HALO Buy
  • WCC Buy
  • Analyst Count
  • HALO 9
  • WCC 7
  • Target Price
  • HALO $63.78
  • WCC $215.14
  • AVG Volume (30 Days)
  • HALO 2.0M
  • WCC 737.2K
  • Earning Date
  • HALO 05-06-2025
  • WCC 05-01-2025
  • Dividend Yield
  • HALO N/A
  • WCC 1.12%
  • EPS Growth
  • HALO 55.40
  • WCC 10.34
  • EPS
  • HALO 3.76
  • WCC 13.26
  • Revenue
  • HALO $1,084,306,000.00
  • WCC $21,812,500,000.00
  • Revenue This Year
  • HALO $20.06
  • WCC $3.45
  • Revenue Next Year
  • HALO $24.20
  • WCC $4.43
  • P/E Ratio
  • HALO $17.56
  • WCC $12.21
  • Revenue Growth
  • HALO 25.64
  • WCC N/A
  • 52 Week Low
  • HALO $41.28
  • WCC $125.21
  • 52 Week High
  • HALO $70.51
  • WCC $216.17
  • Technical
  • Relative Strength Index (RSI)
  • HALO 58.99
  • WCC 53.79
  • Support Level
  • HALO $58.38
  • WCC $156.35
  • Resistance Level
  • HALO $70.51
  • WCC $165.17
  • Average True Range (ATR)
  • HALO 2.50
  • WCC 5.68
  • MACD
  • HALO 0.88
  • WCC 1.05
  • Stochastic Oscillator
  • HALO 64.61
  • WCC 81.11

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About WCC WESCO International Inc.

Wesco International is an industrial distributor that has three reportable segments, electrical and electronic solutions, communications and security solutions, and utility and broadband solutions. The company offers more than 1.5 million products to its 140,000 active customers through a distribution network of 800 branches, warehouses, and sales offices, including 43 distribution centers. Wesco generates approximately 74% of its sales in the United States, but it has a global reach, with operations in 50 other countries.

Share on Social Networks: